Cure of Helicobacter pylori infection by omeprazole-clarithromycin-based therapy in non-human primates

Journal of Gastroenterology

Volumn 33, Issue 1, 1998, Pages 18-22

  Dubois, Andre ^a,b   Berg, Douglas E ^c   Fiala, Nancy ^a,b   Heman Ackah, Lillie M ^b   Perez Perez, Guillermo I ^d   Blaser, Martin J ^d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastritis; H. pylori; Immunoglobulins; Rhesus monkeys; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH SALICYLATE; CLARITHROMYCIN; IMMUNOGLOBULIN G; KETAMINE; METRONIDAZOLE; OMEPRAZOLE; STOMACH SECRETION INHIBITOR;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DISEASE SEVERITY; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEROLOGY; STOMACH BIOPSY;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; ENZYME INHIBITORS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MACACA MULATTA; MALE; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PENICILLINS; SALICYLATES;

EID: 0031938617     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00009961     Document Type: Article

References (19)

1. Anonymous. Helicobacter pylori in peptic ulcer disease. NIH Consensus Conference. JAMA 1994;272:65-69.
2. Anonymous. IARC monograpy on the evaluation of carcinogenic risks to humans. Vol. 61: Schistosomes, liver flukes and Helicobacter pylori. Lyon. France: International Agency for Research on Cancer, 1994.
3. Riegg SJ, Dunn BE, Blaser MJ. Microbiology and pathogenesis of Helicobacter pylori. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL (eds) Infections of the gastrointestinal tract. New York: Raven Press, 1995:535-550.
4. Hoök-Nikanne J, Aho P, Karkkainen P, et al. The Helicobacter felis mouse model in assessing anti-Helicobacter therapies and gastric mucosal prostaglandin E2 levels. Scand J Gastroenterol 1996;31:334-338.
5. Fox JG, Otto G, Taylor NS, Rosenblad W, Murphy JC. Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo). Infect Immun 1991;59:1875-1880.
6. Krakowka S, Morgan DR, Kraft WG, et al. Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet. Infect Immun 1987;55:2789-2796.
7. Handt LK, Fox JO, Dewhirst FE, et al. Helicobacter pylori isolated from the domestic cat: Public health implications. Infect Immun 1994;62:2367-2374.
8. Dubois A, Fiala N, Heman-Ackah LM, et al. Natural gastric infection with Helicobacter pylori in monkeys. A model for human infection with spiral bacteria. Gastroenterology 1994; 106:1405-1417.
9. Dubois A, Fiala N, Weichbrod RH, et al. Seroepizootiology of H. pylori gastric infection in socially housed rhesus monkeys. J Clin Microbiol 1995;33:1492-1495.
10. Dubois A, Berg DE, Incecik ET, et al. Transient and persistent experimental infection of non-human primates with Helicobacter pylori: Implications for human disease. Infect Immun 1996; 64:2885-2891.
11. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;I:1311-1315.
12. Genta RM, Robason Go, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: A new stain. Hum Pathol 1994;25:221-226.
13. Drumm B, Perez-Perez GI, Blaser MJ, et al. Intrafamilial clustering of Helicobacter pylori infection. New Engl J Med 1990; 322:359-363.
14. Perez-Perez GI, Dworkin BM, Chodos JE, et al. Campylobacter pylori antibodies in humans. Ann Int Med 1988; 109:11-17.
15. al-Assi MT, Genta RM, Karttunen TJ, et al. Clarithromycin-amoxicillin therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1994,8:453-456.
16. al-Assi MT, Ramirez FC, Lew GM, et al. Clarithromycin, tetra cycline, and bismuth: A new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994;89:1203-1205.
17. Mégraud F. What is the clinical relevance of Helicobacter pylori resistance to antibiotics. In: Hunt RH, Tytgat GAT. Helicobacter pylori. From basic mechanisms to clinical care. Amsterdam: Kluwer, 1996.
18. Vasquez A, Valdez Y, Gilman RH, et al. Metronidazole and clarithromycin resistance in Helicobacter pylori determined by measuring MICs of antimicrobial agents in color indicator egg yolk agar in a miniwell format. J Clin Microbiol 1996;34:1232-1234.
19. Kosunen TU, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-895.